AG-GLICLAZIDE MR
AG-GLICLAZIDE MR
Approved
DIN Number
02483319
Drug Class
Human
Market Date
Feb 3, 2025
Company
HC
angita pharma inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02483319
AIG Number0119934003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BB09 GLICLAZIDE
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification68:20.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
GLICLAZIDEActive
Strength: 60 MG
Monograph: GLICLAZIDE